HOME ȸ»ç¼Ò°³ ½ÃÀÛÆäÀÌÁö·Î Áñ°Üã±âÃß°¡ ±âÀÚȸ¿ø½Åû
[¸ð¹ÙÀϸðµå] ·Î±×ÀΠȸ¿ø°¡ÀÔ
2024³â03¿ù29ÀÏfri
±â»çÃÖÁ¾ÆíÁýÀÏ: 2024-03-29 19:14:17
´º½ºÈ¨ > µ¿Á¤
2020³â06¿ù16ÀÏ 13½Ã53ºÐ
±ÛÀÚÅ©±â ±â»ç³»¿ë À̸ÞÀϺ¸³»±â ´º½ºÇÁ¸°Æ®Çϱ⠴º½º½ºÅ©·¦Çϱâ
ÇѾç´ë±¸¸®º´¿ø ÇãÁØ¿µ±³¼ö ¡®2020³âµµ Çѱ¹¾ÏÇмúÀç´Ü Çмú»ó¡¯ ¼ö»ó

[º¸°ÇŸÀÓÁî] ÇѾç´ëÇб³±¸¸®º´¿ø Ç÷¾×Á¾¾ç³»°ú ÇãÁØ¿µ ±³¼ö°¡ ´ëÇÑÁ¾¾ç³»°úÇÐȸ¿¡¼­  ÀÓ»ó ¾Ï ¿¬±¸ ºÐ¾ßÀÇ ³í¹®À¸·Î ‘2020³â Çѱ¹¾ÏÇмúÀç´Ü Çмú»ó’À» ¼ö»óÇß´Ù.

Çã±³¼ö´Â Oncoimmunology (IF=5.33)¿¡ °ÔÀçµÈ 'Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment' ¶ó´Â Á¦¸ñÀÇ ³í¹®À¸·Î À§ »óÀ» ¼ö»óÇß´Ù.

ÀÌ¿Í °ü·Ã Çã ±³¼ö´Â “¸é¿ªÇ×¾ÏÁ¦ Åõ¿© ÀüÈÄ T¸²ÇÁ±¸ÀÇ º¯È­ÆÐÅÏÀ» ÅëÇÏ¿© ¸é¿ªÇ×¾ÏÁ¦ ºÎÀÛ¿ëÀÇ ±âÀüÀ» ¹àÈ÷°íÀÚ ÇÑ ³í¹®À¸·Î, À̹ø ¿¬±¸ °á°ú¸¦ Åä´ë·Î ¸é¿ªÇ×¾ÏÁ¦ °ü·Ã ºÎÀÛ¿ëÀ» Ä¡·áÇÏ´Â ±Ù°Å¸¦ Á¦½ÃÇÏ°íÀÚ ÇÑ´Ù”°í ¼Ò°¨À» ¹àÇû´Ù.
 
ÇãÁØ¿µ ±³¼ö´Â ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐÀ» Á¹¾÷ÇÏ°í, °æÈñ´ë ´ëÇпø¿¡¼­ ¼®»ç¿Í ¼º±Õ°ü´ë ´ëÇпø ¹Ú»ç ¼ö·á ¹× »ï¼º¼­¿ïº´¿ø Ç÷¾×Á¾¾ç³»°ú Àӻ󰭻縦 ¼ö·áÇÏ¿´À¸¸ç, ´ëÇѳ»°úÇÐȸ, ´ëÇѾÏÇÐȸ, ´ëÇÑÇ÷¾×ÇÐȸ, ´ëÇÑÁ¾¾ç³»°úÇÐȸ, ´ëÇÑÇ׾Ͽä¹ý¿¬±¸È¸, ¹Ì±¹¾Ï¿¬±¸ÇÐȸ (American Association for Cancer   Research, AACR) µî¿¡¼­ È°¹ßÇÑ È°µ¿À» ÇÏ°í ÀÖ´Ù.

 

 

 

°ü·Ã±â»ç°¡ ¾ø½À´Ï´Ù
´º½º½ºÅ©·¦Çϱâ
Á¶ÇöÁø (bkimes@naver.com) ±âÀÚ 
À̱âÀÚÀÇ ´Ù¸¥´º½ºº¸±â
µ¿Á¤¼½¼Ç ¸ñ·ÏÀ¸·Î
ÀÎõ¼º¸ð È«½Â¸ð º´¿øÀå, '...
°¡Å縯ÀÇ´ë ±è³ª¿¬ ±³¼ö '...
»ó°è¹éº´¿ø ½Å°æ°ú ¹éÁ¾»ï ...
ÀÎÇϴ뺴¿ø À̵ÎÀÍ ±³¼ö, ...
ÇÏÀϼö ±³¼ö, ´ëÇѼҾƽÅÀå...
´ÙÀ½±â»ç : º¸¶ó¸Åº´¿ø-¼­¿ï´ë ¿¬±¸Áø ³í¹®, 'çÈ ±¹Á¦ÇмúÁö Ç¥Áö' Àå½Ä (2020-06-17 09:06:23)
ÀÌÀü±â»ç : °­µ¿°æÈñ´ëº´¿ø ÁÖ±¤·Î ±³¼ö, ´ëÇѼÒÈ­±â¾ÏÇÐȸ ȸÀå ¼±Ãâ (2020-06-15 11:14:14)
º´¿ø°è, "°è...
º´¿ø°è, "°è¹¦³â...
Á¦¾à¡¤°Ç½Ä 12°³...
°Çº¸°ø´Ü, ¼Ò¼Ó±â°ü '¼­¿ï¿ä¾ç...
¼ºÀåÇÏ°íÇ ´ç½Å, "Áö±Ý ´ë¿õ,...
º¸·ÉÁ¦¾à, ¿Ã »ó¹Ý±â '¿µ¾÷Á÷ ...
°Çº¸°ø´Ü, ¿ÃÇØ '°³¹æÇü Á÷°ú ...
°Çº¸°ø´Ü, '¿Ã Á¦3Â÷ °³¹æÇü ...
³í¹®) Inhalation Delivery of Interferon-¥ë-Loaded....  
ȸ»ç¼Ò°³ °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ ÀÌ¿ë¾à°ü À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ ¾Ë¸³´Ï´Ù º¸µµÀÚ·á ±â»çÁ¦º¸ Á¤±â±¸µ¶